Impact of botanical oils on polyunsaturated fatty acid metabolism and leukotriene generation in mild asthmatics

Lipids in Health and Disease

Volumn 12, Issue 1, 2013, Pages

  Arm, Jonathan P ^a,b,d   Boyce, Joshua A ^a,b,c   Wang, Lin ^a   Chhay, Heng ^a   Zahid, Muhammad ^a   Patil, Vaishali ^a   Govindarajulu, Usha ^a   Ivester, Priscilla ^c   Weaver, Kelly L ^c,e   Sergeant, Susan ^c   Israel, Elliot ^a,b   Chilton, Floyd H ^c  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c WAKE FOREST SCHOOL OF MEDICINE   (United States)

^d NOVARTIS PHARMA AG   (Switzerland)

^e UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Asthma; Borage oil; Echium oil; Gammalinolenic acid; Inflammation; Leukotrienes; Stearidonic acid

Indexed keywords

5 HYDROXYICOSATETRAENOIC ACID; ARACHIDONIC ACID; BORAGE OIL; CALCIMYCIN; DIHOMO GAMMA LINOLENIC ACID; DOCOSAPENTAENOIC ACID; ECHIUM OIL; GAMMA LINOLENIC ACID; ICOSAPENTAENOIC ACID; LEUKOTRIENE B4; LINOLENIC ACID; PEPTIDOLEUKOTRIENE; POLYUNSATURATED FATTY ACID; STEARIDONIC ACID; UNCLASSIFIED DRUG; VEGETABLE OIL;

ADULT; ARACHIDONIC ACID METABOLISM; ARTICLE; ASTHMA; BASOPHIL; BORAGO; CELL STIMULATION; CLINICAL ARTICLE; CONTROLLED STUDY; DIET SUPPLEMENTATION; ECHIUM; ECHIUM PLANTAGINEUM; FATTY ACID BLOOD LEVEL; FATTY ACID METABOLISM; FEMALE; HUMAN; HUMAN CELL; LIPID ANALYSIS; MALE; METABOLIC INHIBITION; NEUTROPHIL;

BORAGINACEAE; BORAGO OFFICINALIS; ECHIUM; ECHIUM PLANTAGINEUM;

8,11,14-EICOSATRIENOIC ACID; ADOLESCENT; ADULT; ALPHA-LINOLENIC ACID; ASTHMA; CELLS, CULTURED; DIETARY SUPPLEMENTS; ECHIUM; EICOSAPENTAENOIC ACID; FATTY ACIDS, OMEGA-3; FATTY ACIDS, UNSATURATED; FEMALE; GAMMA-LINOLENIC ACID; HUMANS; INFLAMMATION; LEUKOCYTES, MONONUCLEAR; LEUKOTRIENES; MALE; MIDDLE AGED; PLANT OILS; SEEDS;

EID: 84884776995     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/1476-511X-12-141     Document Type: Article

References (34)

1. Characterization of the human cysteinyl leukotriene 2 receptor. Heise CE, O'Dowd BF, Figueroa DJ, Sawyer N, Nguyen T, Im DS, Stocco R, Bellefeuille JN, Abramovitz M, Cheng R, et al. J Biol Chem 2000 275 30531 30536 10851239
2. Characterization of the human cysteinyl leukotriene CysLT1 receptor. Lynch KR, O'Neill GP, Liu Q, Im DS, Sawyer N, Metters KM, Coulombe N, Abramovitz M, Figueroa DJ, Zeng Z, et al. Nature 1999 399 789 793 10.1038/21658 10391245
3. Double-blind, multicentre analysis of the efficacy of borage oil in patients with atopic eczema. Henz BM, Jabolonska S, van de Kerhof PC, Stingl G, Blazczyk M, Vandervalk PG, Veenhuizen R, Muggli R, Raederstorff D, Br J Dermatol 1999 140 685 688 10.1046/j.1365-2133.1999.02771.x 10233322
4. Oral montelukast, inhaled beclomethasone, and placebo for chronic asthma. Malmstrom K, Rodriguez-Gomez G, Guerra J, Villaran C, Pineiro A, Wei LX, Seidenberg BC, Reiss TF, Ann Intern Med 1999 130 487 495 10.7326/0003-4819-130- 6-199903160-00005 10075616
5. Montelukast for treating seasonal allergic rhinitis: a randomized, double-blind, placebo-controlled trial performed in the spring. Philip G, Malmstrom K, Hampel FC, Weinstein SF, LaForce CF, Ratner PH, Malice MP, Reiss TF, Clin Exp Allergy 2002 32 1020 1028 10.1046/j.1365-2222.2002.01422.x 12100048
6. Effect of dietary enrichment with eicosapentaenoic and docosahexaenoic acids on in vitro neutrophil and monocyte leukotriene generation and neutrophil function. Lee TH, Hoover RL, Williams JD, Sperling RI, Ravalese Jr J, Spur BW, Robinson DR, Corey EJ, Lewis RA, Austen KF, N Eng J Med 1985 312 1217 1224 10.1056/NEJM198505093121903
7. Fatty acid and prostaglandin metabolism in children with diabetes mellitus. II. The effect of evening primrose oil supplementation on serum fatty acid and plasma prostaglandin levels. Arisaka M, Arisaka O, Yamashiro Y, Prostaglandin Leukot Essential Fatty Acids 1991 43 197 201 10.1016/0952-3278(91) 90169-6
8. Gamma linolenic acid: an antiinflammatory omega-6 fatty acid. Kapoor R, Huang YS, Current Pharmaceut Biotech 2006 7 531 534 10.2174/138920106779116874
9. Anti-atherosclerotic effects of dihomo-gamma-linolenic acid in ApoE-deficient mice. Takai S, Jin D, Kawashima H, Kimura M, Shiraishi-Tateishi A, Tanaka T, kakutani S, Tanaka K, Kisa Y, Miyazaki M, J Atherosclerosis Thromb 2009 16 480 489 10.5551/jat.No430
10. Dietary substitution with an alpha-linolenic acid-rich vegetable oil increases eicosapentaenoic acid concentrations in tissues. Mantzioris E, James MJ, Gibson RA, Cleland LG, Am J Clin Nutr 1994 59 1304 1309 7910999
11. Dietary stearidonic acid is a long chain (n-3) polyunsaturated fatty acid with potential health benefits. Whelan J, J Nutr 2009 139 5 10 19056654
12. Expert panel report 2: guidelines for the diagnosis and management of asthma. Department Health and Human Services N, NHLBI, NIH Publication No 07-4051 2007 http://www.nhlbi.nih.gov/guidelines/asthma/asthgdln.pdf
13. Dietary supplementation with gamma -linolenic acid alters fatty acid content and eicosanoid production in healthy humans. Johnson MM, Swan DD, Surette ME, Stegner J, Chilton T, Fonteh AN, Chilton FH, J Nutr 1997 127 1435 1444 9237935
14. Rapid preparation of fatty acid esters from lipids for gas chromatographic analysis. Metcalfe LD, Schmitz AA, Pelka JR, Anal Chem 1966 38 514 515 10.1021/ac60235a044
15. Effect of dietary fatty acids on inflammatory gene expression in healthy humans. Weaver KL, Ivester P, Seeds MC, Case LD, Arm J, Chilton FH, J Biol Chem 2009 284 15400 15407 10.1074/jbc.M109.004861 19359242
16. Leukocyte immunoglobulin-like receptors: novel innate receptors for human basophil activation and inhibition. Sloane DE, Tedla N, Awoniyi M, MacGlashan DW Jr, Borges L, Austen KF, Arm JP, Blood 2004 104 2832 2839 10.1182/blood-2004-01-0268 15242876
17. Isolation of human neutrophils from venous blood. Nauseef WM, Meth Mol Biol 2007 412 15 20 10.1007/978-1-59745-467-4-2
18. Effect of dihomogammalinolenic acid and its 15-lipoxygenase metabolite on eicosanoid metabolism by human mononuclear leukocytes in vitro: selective inhibition of the 5-lipoxygenase pathway. Iversen L, Fogh K, Kragballe K, Archives of Dermatol Res 1992 284 222 226 10.1007/BF00375798
19. Alpha-linolenic acid and coronary heart disease. de Lorgeril M, Salen P, Nutr Metab Cardiovas Dis 2004 14 162 169 10.1016/S0939-4753(04)80037-1
20. Enzymes and receptors of prostaglandin pathways with arachidonic acid-derived versus eicosapentaenoic acid-derived substrates and products. Wada M, DeLong CJ, Hong YH, Rieke CJ, Song I, Sidhu RS, Yuan C, Warnock M, Schmaier AH, Yokoyama C, et al. J Biol Chem 2007 282 22254 22266 10.1074/jbc.M703169200 17519235
21. Reduced asthma symptoms with n-3 fatty acid ingestion are related to 5-series leukotriene production. Broughton KS, Johnson CS, Pace BK, Liebman M, Kleppinger KM, Am J Clin Nutr 1997 65 1011 1017 9094887
22. Docosapentaenoic acid (22:5n-3): a review of its biological effects. Kaur G, Cameron-Smith D, Garg M, Sinclair AJ, Prog Lipid Res 2011 50 28 34 10.1016/j.plipres.2010.07.004 20655949
23. n-3 Polyunsaturated fatty acids and inflammation: from molecular biology to the clinic. Calder P, Lipids 2003 38 343 352 10.1007/s11745-003-1068-y 12848278
24. Increased arachidonate in lipids after administration to man: effects on prostaglandin biosynthesis. Seyberth HW, Oelz O, Kennedy T, Sweetman BJ, Danon A, Frolich JC, Heimberg M, Oates JA, Clin Pharmacol Ther 1975 18 521 529 1102230
25. Addition of eicosapentaenoic acid to g-linolenic acid-supplemented diets prevents serum arachidonic acid accumulation in humans. Barham JB, Edens MB, Fonteh AN, Johnson MM, Easter L, Chilton FH, J Nutr 2000 130 1925 1931 10917903
26. Inhibition of leukotriene synthesis, pharmacokinetics, and tolerability of a novel dietary fatty acid formulation in healthy adult subjects. Surette ME, Koumenis IL, Edens MB, Tramposch KM, Chilton FH, Clin Therapeut 2003 25 948 971 10.1016/S0149-2918(03)80116-9
27. Inhibition of leukotriene biosynthesis by a novel dietary fatty acid formulation in patients with atopic asthma: a randomized, placebo-controlled, parallel-group, prospective trial. Surette ME, Koumenis IL, Edens MB, Tramposch KM, Clayton B, Bowton D, Chilton FH, Clin Therapeut 2003 25 972 979 10.1016/S0149-2918(03)80117-0
28. Basophil recruitment and IL-4 production during human allergen-induced late asthma. Nouri-Aria KT, Irani AM, Jacobson MR, O'Brien F, Varga EM, Till SJ, Durham SR, Schwartz LB, J Allergy Clin Immunol 2001 108 205 211 10.1067/mai.2001.117175 11496235
29. Treatment of allergic asthma with monoclonal anti-IgE antibody. Milgrom H, Fick RB, Su JQ, Reimann JD, Bush RK, Watrous ML, Metzger WJ, N Eng J Med 1999 341 1966 1973 10.1056/NEJM199912233412603
30. Sulphidopeptide leukotrienes in asthma. Arm JP, Lee TH, Clin Sci 1993 84 501 510 8389264
31. Effect of dietary supplementation with fish oil lipids on mild asthma. Arm JP, Horton CE, Mencia-Huerta JM, House F, Eiser NM, Clark TJ, Spur BW, Lee TH, Thorax 1988 43 84 92 10.1136/thx.43.2.84 3353893
32. The effects of dietary supplementation with fish oil lipids on the airways response to inhaled allergen in bronchial asthma. Arm JP, Horton CE, Spur BW, Mencia-Huerta JM, Lee TH, Am Rev Respir Dis 1989 139 1395 1400 10.1164/ajrccm/139.6.1395 2543246
33. Effects of exogenous arachidonic, eicosapentaenoic, and docosahexaenoic acids on the generation of 5-lipoxygenase pathway products by ionophore-activated human neutrophils. Lee TH, Mencia-Huerta JM, Shih C, Corey EJ, Lewis RA, Austen KF, J Clin Invest 1984 74 1922 1933 10.1172/JCI111612 6096400
34. n-3 Polyunsaturated fatty acids, inflammation, and inflammatory diseases. Calder PC, Am J Clin Nutr 2006 83 1505 S1519